Tag: DTC advertising

DTC advertising

AMA Calls for DTC Advertising Ban

Nov. 17, 2015 — The American Medical Association (AMA) announced today that it would support an advertising ban on direct-to-consumer (DTC) advertising in an effort to make prescription drugs more affordable and address member concerns regarding “the negative impact of commercially-driven promotions and the role that marketing costs play in fueling escalating drug prices.” The […]

Read more

Kaiser Poll: DTC Ads Have High Profile, But Mixed Reviews

Oct. 30, 2015 – The drug industry may have additional work to do to improve the public’s perception of its advertising, according to Kaiser Health Tracking Poll findings reported Oct. 28. Although a high percentage of the public (82 percent) reports having seen or heard a prescription drug direct-to-consumer (DTC) ad, only 51 percent of […]

Read more

Prescription Drug Marketing Targeted by Hillary Clinton

Sept. 24, 2015 – Presidential hopeful Hillary Clinton just announced that she would “demand a stop to excessive profiteering and marketing by denying tax breaks for direct-to-consumer [DTC] advertising and demanding that drug companies invest in R&D in exchange for taxpayer support,” according to a briefing released this week by her campaign. Under Clinton’s plan, […]

Read more

2014 DTC Ad Spending on the Rise

March 25, 2015 – The amount of money that drug companies spent on direct-to-consumer advertising rose from $3.8 billion in 2013 to $4.5 billion in 2014, a potential signal of both a recovering economy and industry’s desire to speak more directly to the patients who are gaining more control of their own healthcare. According to […]

Read more

DAA Expands Ad Privacy Controls to Mobile Marketplace

Feb. 26, 2015 – To “bolster both consumer trust and marketplace growth,” the Digital Advertising Alliance (DAA) yesterday launched two new mobile tools for consumers that provide “transparency and choice over data collection wherever and however they access the Internet,” according to DAA General Counsel Stu Ingis. The new mobile tools – “AppChoices” and the […]

Read more

Revised Guidance on Use of Brief Summary in Print DTC Ads: Full PI Is Not Needed or “Recommended”

Feb. 9, 2015 – In a revised draft guidance document released Feb. 6, the FDA is updating a 2004 version that covers brief summary requirements for consumer-directed print drug ads by calling for standardized formats that are easier for consumers to read and understand and recommending that drug firms do not disseminate the full, FDA-approved […]

Read more

FDA Plans to Study Effect of DTC Ads on Adolescents

July 24, 2014 – A better understanding of how adolescents weigh risks and benefits in direct-to-consumer (DTC) ads is needed to address concerns the FDA has about this vulnerable population, the agency stated in a notice published July 21 in the Federal Register (2014-16998). “Adolescents are a unique audience for DTC drug marketing because their […]

Read more

FDA Social Media Draft Guidances Answer Some Questions, Raise Others

July 21, 2014 – Although the FDA has attempted to provide some clarity on its position regarding certain social media issues and practices, the agency’s recent draft guidance documents do not leave industry communicators with a crystal clear path and, indeed, “raise some important questions that communicators may have for their counsel,” according to Mark […]

Read more